EP1718607A4 - COMPOSITIONS BASED ON MODAFINIL - Google Patents

COMPOSITIONS BASED ON MODAFINIL

Info

Publication number
EP1718607A4
EP1718607A4 EP05712282A EP05712282A EP1718607A4 EP 1718607 A4 EP1718607 A4 EP 1718607A4 EP 05712282 A EP05712282 A EP 05712282A EP 05712282 A EP05712282 A EP 05712282A EP 1718607 A4 EP1718607 A4 EP 1718607A4
Authority
EP
European Patent Office
Prior art keywords
modafinil compositions
modafinil
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP05712282A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1718607A1 (en
Inventor
Hickey Magali Bourghol
Matthew Peterson
Orn Almarsson
Mark Oliveira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/029013 external-priority patent/WO2005023198A2/en
Application filed by Cephalon LLC filed Critical Cephalon LLC
Priority to EP10001997A priority Critical patent/EP2292213A1/en
Publication of EP1718607A1 publication Critical patent/EP1718607A1/en
Publication of EP1718607A4 publication Critical patent/EP1718607A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
EP05712282A 2004-02-06 2005-02-01 COMPOSITIONS BASED ON MODAFINIL Ceased EP1718607A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10001997A EP2292213A1 (en) 2004-02-06 2005-02-01 Compositions comprising a polymorphic form of armodafinil

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US54275204P 2004-02-06 2004-02-06
US56041104P 2004-04-06 2004-04-06
US57341204P 2004-05-21 2004-05-21
US57917604P 2004-06-12 2004-06-12
US58199204P 2004-06-22 2004-06-22
US58675204P 2004-07-09 2004-07-09
US58823604P 2004-07-15 2004-07-15
PCT/US2004/029013 WO2005023198A2 (en) 2003-09-04 2004-09-04 Modafinil compositions
US63178604P 2004-11-30 2004-11-30
PCT/US2005/002782 WO2005077894A1 (en) 2004-02-06 2005-02-01 Modafinil compositions

Publications (2)

Publication Number Publication Date
EP1718607A1 EP1718607A1 (en) 2006-11-08
EP1718607A4 true EP1718607A4 (en) 2008-05-28

Family

ID=38456572

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05712282A Ceased EP1718607A4 (en) 2004-02-06 2005-02-01 COMPOSITIONS BASED ON MODAFINIL

Country Status (7)

Country Link
EP (1) EP1718607A4 (enExample)
JP (1) JP4917441B2 (enExample)
AU (1) AU2005212229B2 (enExample)
CA (1) CA2556106A1 (enExample)
EA (1) EA009949B1 (enExample)
IL (1) IL176934A (enExample)
WO (1) WO2005077894A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050025791A1 (en) 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
WO2007062147A1 (en) * 2005-11-22 2007-05-31 Teva Pharmaceutical Industries Ltd. Crystal forms of cinacalcet hci and processes for their preparation
CN100343228C (zh) * 2006-02-17 2007-10-17 中国科学院上海有机化学研究所 高对映体选择性制备 2－二苯甲基亚磺酰基－乙酰胺单一对映体的方法
WO2007098273A2 (en) * 2006-02-21 2007-08-30 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of armodafinil and preparation thereof
CA2688430A1 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
US7960586B2 (en) 2007-08-16 2011-06-14 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
US20090105346A1 (en) * 2007-10-02 2009-04-23 Alexandr Jegorov Novel crystalline forms of armodafinil and preparation thereof
WO2009090663A1 (en) * 2008-01-15 2009-07-23 Lupin Limited Novel crystalline polymorph of armodafinil and an improved process for preparation thereof
KR102126389B1 (ko) * 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233106A1 (fr) * 1986-01-31 1987-08-19 Laboratoire L. Lafon (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804322B1 (fr) * 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
KR101081212B1 (ko) * 2000-07-27 2011-11-07 테바 파마슈티컬 인더스트리즈 리미티드 결정질의 순수한 모다피닐 및 이의 제조 방법
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233106A1 (fr) * 1986-01-31 1987-08-19 Laboratoire L. Lafon (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Provigil (modafinil) tablets [C-IV]", FDA APROVED LABELING TEXT FOR NDA 20-717/S-005 & S-008, 23 January 2004 (2004-01-23), pages 1 - 35, XP002475473 *
See also references of WO2005077894A1 *

Also Published As

Publication number Publication date
EA200601390A1 (ru) 2006-12-29
EP1718607A1 (en) 2006-11-08
AU2005212229A1 (en) 2005-08-25
JP2007522147A (ja) 2007-08-09
EA009949B1 (ru) 2008-04-28
IL176934A0 (en) 2006-12-10
AU2005212229B2 (en) 2011-06-09
CA2556106A1 (en) 2005-08-25
JP4917441B2 (ja) 2012-04-18
IL176934A (en) 2013-06-27
WO2005077894A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
ZA200904425B (en) Nemathical compositions
EP1718714A4 (en) COMPOSITIONS CONTAINING A PLOTTER
GB0409375D0 (en) Phytoactive composition
GB0405406D0 (en) Anti-vaginitis compositions
GB0416861D0 (en) Composition
GB0425795D0 (en) Composition
GB0414803D0 (en) Composition
GB0410038D0 (en) Composition
EP1726304A4 (en) COMPOSITION CONTAINING SOLIFENACIN
IL176934A0 (en) Modafinil compositions
GB0415981D0 (en) Composition
GB0417357D0 (en) Composition
ZA200701197B (en) Compositions
GB0410140D0 (en) Compositions
ZA200704974B (en) Composition
GB0420627D0 (en) Monoglyceride-containing compositions
GB0425445D0 (en) Novel compositions
GB0417388D0 (en) Composition
IL173575A0 (en) Modafinil compositions
ZA200606337B (en) Modafinil compositions
GB0517958D0 (en) Weathered-effect composition
GB0409598D0 (en) Composition
HK1096381A (en) Modafinil compositions
GB0407815D0 (en) Compositions
GB0412304D0 (en) Compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1096381

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/165 20060101ALI20080416BHEP

Ipc: C07C 315/06 20060101ALI20080416BHEP

Ipc: C07C 317/48 20060101AFI20080416BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20080428

17Q First examination report despatched

Effective date: 20080910

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20100517

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1096381

Country of ref document: HK